These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Chronic renal failure after hematopoietic stem cell transplantation]. Boscutti G; Pizzolitto S; Patriarca F; De Maglio G; Bosco M; Boer E G Ital Nefrol; 2008; 25(4):459-74. PubMed ID: 18663693 [TBL] [Abstract][Full Text] [Related]
4. Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis. Bramow S; Faber-Rod JC; Jacobsen C; Kutzelnigg A; Patrikios P; Sorensen PS; Lassmann H; Laursen H Mult Scler; 2008 Jun; 14(5):711-5. PubMed ID: 18566036 [TBL] [Abstract][Full Text] [Related]
5. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. Denney DR; Lynch SG; Parmenter BA J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653 [TBL] [Abstract][Full Text] [Related]
6. Sensory impairments in quiet standing in subjects with multiple sclerosis. Cattaneo D; Jonsdottir J Mult Scler; 2009 Jan; 15(1):59-67. PubMed ID: 18845654 [TBL] [Abstract][Full Text] [Related]
7. Is progressive multiple sclerosis a gray matter disease? Geurts JJ Ann Neurol; 2008 Sep; 64(3):230-2. PubMed ID: 18825672 [No Abstract] [Full Text] [Related]
8. Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis. Conte A; Bettolo CM; Onesti E; Frasca V; Iacovelli E; Gilio F; Giacomelli E; Gabriele M; Aragona M; Tomassini V; Pantano P; Pozzilli C; Inghilleri M Eur J Pain; 2009 May; 13(5):472-7. PubMed ID: 18603457 [TBL] [Abstract][Full Text] [Related]
9. Defining the natural history of MS: the need for complete data and rigorous definitions. Tremlett H; Zhao Y; Devonshire V Mult Scler; 2008 Sep; 14(8):1142-3; author reply 1144-7. PubMed ID: 18701573 [No Abstract] [Full Text] [Related]
10. Iron overload in hematopoietic cell transplantation. Majhail NS; Lazarus HM; Burns LJ Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425 [TBL] [Abstract][Full Text] [Related]
11. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G; Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Liang J; Zhang H; Hua B; Wang H; Wang J; Han Z; Sun L Mult Scler; 2009 May; 15(5):644-6. PubMed ID: 19389752 [TBL] [Abstract][Full Text] [Related]
13. [Neuropsychology of primary progressive multiple sclerosis]. Paes RA; Alvarenga RM; Vasconcelos CC; Negreiros MA; Landeira-Fernández J Rev Neurol; 2009 Oct 1-15; 49(7):343-8. PubMed ID: 19774527 [TBL] [Abstract][Full Text] [Related]
15. Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope. Hartung HP; Aktas O Ann Neurol; 2009 Oct; 66(4):429-32. PubMed ID: 19847907 [No Abstract] [Full Text] [Related]